AI assistant
Sending…
Winpak Ltd — Regulatory Filings 2020
Mar 3, 2020
42846_rns_2020-03-03_b341934d-c21f-4178-b324-5afa4b6fbff3.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Note: [01 Mar 2017] – The following is a consolidation of 13-501F1. It incorporates amendments to this document
that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative.
FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS -PARTICIPATION FEE
MANAGEMENT CERTIFICATION
| I, Larry Warelis Form 13-501F1 (the Form) being submitted hereunder to the Alberta Securities Commission and certify that to my knowledge, having exercised reasonable diligence, the information provided in the Form is complete and accurate. Lung Wareling |
||||||
|---|---|---|---|---|---|---|
| March 3, 2020 | ||||||
| Name: Larry Warelis Title: Vice President & CFO |
Date: | |||||
| Reporting Issuer Name: | Winpak Ltd. | |||||
| End date of previous financial year: | December 29, 2019 | |||||
| Type of Reporting Issuer: | $[\times]$ Class 1 reporting issuer |
issuer | Class 3B reporting | |||
| Highest Trading Marketplace: | Toronto Stock Exchange | |||||
| Market value of listed or quoted equity securities: | ||||||
| Equity Symbol | WPK. | |||||
| 1st Specified Trading Period (dd/mm/yy) | 31/12/18 | to to | 31/03/19 | |||
| Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace |
\$ (i) |
43.1300 |
| Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period |
(ii) | 65,000,000 | ||
|---|---|---|---|---|
| Market value of class or series | $(i)$ x $(ii)$ | \$ (A) |
2,803,450,000 | |
| 2nd Specified Trading Period (dd/mm/yy) | 01/04/19 | to | 30/06/19 | |
| Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace |
\$ (iii) |
43.2000 | ||
| Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period |
(iv) | 65,000,000 | ||
| Market value of class or series | $(iii)$ x $(iv)$ | \$ (B) |
2,808,000,000 | |
| 3rd Specified Trading Period (dd/mm/yy) | 01/07/19 | to | 29/09/19 | |
| Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace |
\$ (v) |
43.8900 | ||
| Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period |
(v i ) | 65,000,000 | ||
| Market value of class or series | $(v)$ x $(vi)$ | \$ (C) |
2,852,850,000 |
| 29/12/19 | ||
|---|---|---|
| \$ (vii) |
47.4600 | |
| (viii) | 65,000,000 | |
| $\mathbb{S}$ (D) |
3,084,900,000 | |
| to | ||
| \$ (ix) |
||
| (x) | ||
| \$ (E) |
||
| \$ | 2,887,300,000 | |
| $(vii)$ x $(viii)$ $(ix) \times (x)$ |
30/09/19 (1) |
to |
(Repeat the above calculation for each other class or series of equity securities of the reporting
issuer (and a subsidiary, if applicable) that was listed or quoted on a marketplace at the end of the
previous financial ye
Fair value of outstanding debt securities:
| (Provide details of how value was determined) | (2) | 0.0000 | |
|---|---|---|---|
| Capitalization for the previous financial year | $(1) + (2)$ | $\mathcal{S}$ | 2,887,300,000 |
| Participation Fee | $\mathbb{S}$ | 28,000.0000 | |
| Late Fee, if applicable | 0.0000 | ||
| Total Fee Payable (Participation Fee plus Late Fee) |
\$ | 28,000.0000 |
More from Winpak Ltd
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 26